Jeff Aronin: A Pioneer in the Biotechnology Sector

Paragon Biosciences is a company that invests in innovative biotechnology companies. The goal of Paragon is to build up companies that can discover treatments for rare and previously untreatable diseases. Paragon has had 13 new drugs approved by the FDA in the past 10 years. Some of the investment partners for Paragon include Fidelity Investments, Diaderm, Debra Austria, and Valor Equity Partners.

Castle Creek Pharmaceuticals (CCP) is a Paragon portfolio company specializing in finding treatments for rare dermatologic diseases. The company has created numerous innovative drugs and therapies that have the potential to treat many of these diseases.

Harmony Biosciences is another portfolio company dedicated to finding cures and treatments for patients with sleep and central nervous system problems.

Jeff Aronin assumed the role of Chairman and CEO of Paragon Biosciences in 2010. He also is the chairman of several successful Paragon portfolio companies. Jeff Aronin founded Ovation Pharmaceuticals in 2000 and served as that company’s president and CEO until 2009. Lundbeck, Inc. acquired Ovation Pharmaceuticals in 2009 and Jeff Aronin stayed on as the CEO and president during the merger. Jeff Aronin has over 20 years of experience in creating biotechnology companies (Reporterexpert). He is highly respected in the bioscience industry because of his vast contributions and knowledge. Jeff also mentors aspiring entrepreneurs in the field.

Jeff Aronin is dedicated to philanthropy and supports numerous non-profit organizations such as the Susan G. Komen Foundation, the Liver Life Challenge, Juvenile Diabetes, the Teaching Tolerance, the Jewish United Fund, the Boys and Girls Club of Chicago, and the Chicago Parks Foundation.

Jeff has also received countless awards throughout his career that include: the 2017 Weizmann Leadership Award, Buyouts Magazine “Deal of the year in 2010,” Epilepsy Foundation of Chicago Rovner Award in 2007, and the Holocaust Museum and Education Center’s Humanitarian Award in 2010. Despite his success, Jeff Aronin will not be satisfied until treatments are found for all untreatable diseases.